4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-18-002673
Options or other derivatives
- Chief Executive Officer acquired 2,104,056 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Noble James Chief Executive Officer | 2018-01-12 | Grant or award · Option to purchase Ordinary Shares | +1,719,936 | 1,719,936 | D | ||
| Noble James Chief Executive Officer | 2018-01-12 | Grant or award · Option to purchase Ordinary Shares | +384,120 | 384,120 | D | ||
Loading xslF345X03/a4.xml…